The story of Viagra, initially marketed by copyright, presents a complex case study for stakeholders considering the healthcare sector. While its initial success and creation of vast in earnings , the patent end has opened the door for alternative medications, significantly diminishing earnings prospects . This shift raises concerns about the conti